Global Non-Invasive Prenatal Testing Market to Reach US$ 5,000 Mn by 2027

1. ©2019 Transparency Market Research, All Rights Reserved Non-invasive prenatal testing (NIPT) is a novel genetic screening method based on the analysis of cell-free fetal DNAin the maternal plasma Peptide Therapeutics Market ©2019 Transparency Market Research, All Rights Reserved

2. ©2019 Transparency Market Research, All Rights Reserved Non-Invasive Prenatal Testing Market - Snapshot  Non-invasive prenatal testing (NIPT) is a novel genetic screening method based on the analysis of cell-free fetal DNA in the maternal plasma.  The market for non-invasive prenatal testing is expanding significantly, worldwide, p rimarily due to increasing incidences of chromosomal aneuploidies among fetus, rising demand for early and non-invasive screening procedures, and rise in advanced maternal age (earlier 23 to 26 years has increased to 30 years)  The global non-invasive prenatal testing market was valued at US$ 1,300 Mn in 2018 and is anticipated to reach US$ 5,000 Mn by 2027, expanding at a CAGR of 16% from 2019  In terms of application, the global non-invasive prenatal testing market has been classified symptoms, and others (Sex Chromosomes Disorders). into trisomy, microdeletions

3. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Outlook Chapter 6 Global Non-Invasive Prenatal Testing Market, by Test Type Chapter 7 Global Non-Invasive Prenatal Testing Market, by Application Chapter 8 Global Non-Invasive Prenatal Testing Market, by Technology Chapter 9 Global Non-Invasive Prenatal Testing Market, by End-user Chapter 10 Global Non-Invasive Prenatal Testing Market, by Region

4. ©2019 Transparency Market Research, All Rights Reserved Trisomy segment to expand at rapid pace In terms of application, the global non-invasive prenatal testing market has been classified into Trisomy, Microdeletions Symptoms, and others (Sex Chromosomes Disorders).The trisomy segment is anticipated to expand at a notable CAGR in the near future. According to the CDC, Down’s syndrome is considered to be a common chromosomal disorder in the U.S. Around 6,000 babies (1 in 700 babies) are born with Down’s syndrome in the U.S., each year, and a rise in the cases of Down’s syndrome has fueled concerns among healthcare practitioners in the U.S.Increasing new cases of Down’s syndrome among live births in the U.S. is a leading factor attributed to the notable share held by the trisomy segment of the global non-invasive prenatal testing market in 2018. Request Brochure of Report ©2019 Transparency Market Research, All Rights Reserved

5. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U